Have a personal or library account? Click to login

Does regular quality control improve the quality of surgery in Slovenian breast cancer screening program?

Open Access
|May 2020

References

  1. Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer 2018; 103: 356-87. doi: 10.1016/j.ejca.2018.07.005
  2. Wang F, Shu X, Meszoely I, Pal T, Mayer IA, Yu Z, et al. Overall mortality after diagnosis of breast cancer in men vs women. JAMA Oncol 2019. [Epub ahead of print]. doi: 10.1001/jamaoncol.2019.2803
  3. Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, et al. Breast-cancer screening-viewpoint of the IARC working group. N Engl J Med 2015; 372: 2353-8. doi: 10.1056/NEJMsr1504363
  4. Myers ER, Moorman P, Gierisch JM, Havrilesky LJ, Grimm LJ, Ghate S, et al. Benefits and harms of breast cancer screening: a systematic review. JAMA - J Am Med Assoc 2015; 314: 1615-34. doi: 10.1001/jama.2015.13183
  5. Biganzoli L, Marotti L, Hart CD, Cataliotti L, Cutuli B, Kühn T, et al. Quality indicators in breast cancer care: an update from the EUSOMA working group. Eur J Cancer 2017; 86: 59-81. doi: 10.1016/j.ejca.2017.08.017
  6. Rosselli Del Turco M, Ponti A, Bick U, Biganzoli L, Cserni G, Cutuli B, et al. Quality indicators in breast cancer care. Eur J Cancer 2010; 46: 2344-56. doi: 10.1016/j.ejca.2010.06.119
  7. Perry N, Broeders M, de Wolf C, Tornberg S, Holland R, von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis [Internet]. Eur Guidel 2006 [cited 2020 Mar 30]. Available from: http://screening.iarc.fr/doc/ND7306954ENC_002.pdf
  8. DORA programme colleagues. [Annual Report on the DORA Breast Cancer National Screening Program 2018]. [Slovenian]. [Internet]. Institute of Oncology Ljubljana - DORA National Breast Cancer Screening Programme 2019 [cited 2020 Mar 30]. Available from: https://dora.onko-i.si/fileadmin/user_upload/Dokumenti/DORA_letno_porocilo_2018_knjiznica.pdf
  9. Cicero U, Rietjens M, Mahmoud ET, Virgilio S. Oncoplastic and reconstructive breast surgery Cham: Springer; 2019.
  10. Rizzo M, Bumpers H, Okoli J, Senior-Crosby D, O’Regan R, Zelnak A, et al. Improving on national quality indicators of breast cancer care in a large public hospital as a means to decrease disparities for african american women. Ann Surg Oncol 2011; 18: 34-9. doi: 10.1245/s10434-010-1204-z
  11. Wilcox N, McNeil JJ. Clinical quality registries have the potential to drive improvements in the appropriateness of care. Med J Aust 2016; 205: S27-9. doi: 10.5694/mja15.00921
  12. Cheng SH, Wang CJ, Lin JL, Horng CF, Lu MC, Asch SM, et al. Adherence to quality indicators and survival in patients with breast cancer. Med Care 2009; 47: 217-25. doi: 10.1097/MLR.0b013e3181893c4a.
  13. Van Dam PA, Verheyden G, Sugihara A, Trinh XB, Van Der Mussele H, Wuyts H, et al. A dynamic clinical pathway for the treatment of patients with early breast cancer is a tool for better cancer care: implementation and prospective analysis between 2002-2010. World J Surg Oncol 2013; 11: 70. doi: 10.1186/1477-7819-11-70
  14. Plavc G, Ratoša I, Žagar T, Zadnik V. Explaining variation in quality of breast cancer care and its impact: a nationwide population-based study from Slovenia. Breast Cancer Res Treat 2019; 175: 585-94. doi: 10.1007/s10549-019-05186-z
  15. Henke G, Knauer M, Ribi K, Hayoz S, Gerard MA. Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial. Trials 2018; 19: 667. doi: 10.1186/s13063-018-3021-9
  16. Ojala K, Meretoja TJ, Leidenius MHK. Aesthetic and functional outcome after breast conserving surgery - Comparison between conventional and oncoplastic resection. Eur J Surg Oncol 2017; 43: 658-64. doi:10.1016/j. ejso.2016.11.019
  17. Biganzoli L, Cardoso F, Beishon M, Cameron D, Cataliotti L, Coles CE, et al. The requirements of a specialist breast centre. Breast 2020; 51: 65-84. doi: 10.1016/j.breast.2020.02.003
  18. Van Dam PA, Tomatis M, Marotti L, Heil J, Mansel RE, Rosselli del Turco M, et al. Time trends (2006–2015) of quality indicators in EUSOMA-certified breast centres. Eur J Cancer 2017; 85: 15-22. doi: 10.1016/j. ejca.2017.07.040
  19. Van Dam PA, Tomatis M, Marotti L, Heil J, Wilson R, Rosselli Del Turco M, et al. The effect of EUSOMA certification on quality of breast cancer care. Eur J Surg Oncol 2015; 41: 1423-9. doi: 10.1016/j.ejso.2015.06.006
  20. Hartmann-Johnsen OJ, Kåresen R, Schlichting E, Naume B, Nygård JF. Using clinical cancer registry data for estimation of quality indicators: Results from the Norwegian breast cancer registry. Int J Med Inform 2019; 125: 102-9. doi: 10.1016/j.ijmedinf.2019.03.004
DOI: https://doi.org/10.2478/raon-2020-0030 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 488 - 494
Submitted on: Apr 4, 2020
Accepted on: Apr 26, 2020
Published on: May 28, 2020
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 Andraz Perhavec, Sara Milicevic, Barbara Peric, Janez Zgajnar, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.